Prevalence of thyrotoxicosis, antithyroid medication use, and complications among pregnant women in the United States

Thyroid

Volumn 23, Issue 6, 2013, Pages 758-765

  Korelitz, James J ^a   McNally, Diane L ^b   Masters, Mary N ^a   Li, Sue X ^a   Xu, Yiling ^a   Rivkees, Scott A ^c  

^a Department of Health Studies Westat ^*  (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROPYLTHIOURACIL; THIAMAZOLE; ANTITHYROID AGENT;

ADULT; AGED; ARTICLE; BIRTH DEFECT; CONGENITAL MALFORMATION; CONTROLLED STUDY; FEMALE; HEALTH INSURANCE; HUMAN; ICD-9; LIVER DISEASE; MAJOR CLINICAL STUDY; PREGNANCY OUTCOME; PREGNANT WOMAN; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THYROTOXICOSIS; UNITED STATES; ABNORMALITIES, DRUG-INDUCED; ADOLESCENT; CONGENITAL ABNORMALITIES; DRUG-INDUCED LIVER INJURY; HEPATIC INSUFFICIENCY; INFANT; INTERNATIONAL CLASSIFICATION OF DISEASES; NEWBORN; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE; PRESCRIPTION; YOUNG ADULT;

ABNORMALITIES, DRUG-INDUCED; ADOLESCENT; ADULT; ANTITHYROID AGENTS; CONGENITAL ABNORMALITIES; DRUG PRESCRIPTIONS; DRUG-INDUCED LIVER INJURY; FEMALE; HEPATIC INSUFFICIENCY; HUMANS; INFANT; INFANT, NEWBORN; INSURANCE, HEALTH; INTERNATIONAL CLASSIFICATION OF DISEASES; METHIMAZOLE; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; PREVALENCE; PROPYLTHIOURACIL; RETROSPECTIVE STUDIES; THYROTOXICOSIS; UNITED STATES; YOUNG ADULT;

EID: 84878831978     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2012.0488     Document Type: Article

References (22)

1. Weetman AP 2000 Graves' disease. N Engl J Med 343:1236-1248.
2. Franklyn JA, Boelaert K 2012 Thyrotoxicosis. Lancet 379:1155-1166.
3. Rivkees SA, Mandel S 2011 Thyroid disease in pregnancy. Horm Res Paediatr 76 Suppl 1:91-96.
4. Chan GW, Mandel SJ 2007 Therapy insight: management of Graves' disease during pregnancy. Nat Clin Pract Endocrinol Metab 3:470-478.
5. Abalovich M, Amino N, Barbour LA, Cobin RH, De Groot LJ, Glinoer D, Mandel SJ, Stagnaro-Green A 2007 Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 92:S1-S47.
6. Metsman JH 2004 Hyperthyroidism in pregnancy. Best Pract Res Clin Endocrinol Metab 18:267-288.
7. Barbero P, Valdez R, Rodriguez H, Tiscornia C, Mansilla E, Allons A, Coll S, Liascovich R 2008 Choanal atresia associated with maternal hyperthyroidism treated with methimazole: a case-control study. Am J Med Genet A 146A: 2390-2395.
8. Valdez RM, Barbero PM, Liascovich RC, De Rosa LF, Aguirre MA, Alba LG 2007 Methimazole embryopathy: a contribution to defining the phenotype. Reprod Toxicol 23:253-255.
9. Chattaway JM, Klepser TB 2007 Propylthiouracil versus methimazole in treatment of Graves' disease during pregnancy. Ann Pharmacother 41:1018-1022.
10. Wing DA, Millar LK, Koonings PP, Montoro MN, Mestman JH 1994A comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy. Am J Obstet Gynecol 170:90-95.
11. Mandel SJ, Brent GA, Larsen PR 1994 Review of antithyroid drug use during pregnancy and report of a case of aplasia cutis. Thyroid 4:129-133.
12. Van Dijke CP, Heydendael RJ, De Kleine MJ 1987 Methimazole, carbimazole, and congenital skin defects. Ann Intern Med 106:60-61.
13. Bachrach LK, Burrow GN 1984 Aplasia cutis congenita and methimazole. Can Med Assoc J 130:1264.
14. U.S. Food and Drug Administration Adverse Event Reporting System. www.fda.gov/drugs/guidancecomplianceregulatoryinformation/surveillance/ adversedrugeffects/default.htm (accessed April 20, 2013).
15. Rivkees S, Mattison D 2009 Propylthiouracil (PTU) hepatoxicity in children and recommendations for discontinuation of use. Int J Pediatr Endocrinol 2009:132041.
16. FDA 2010 FDA Drug Safety Communication: New Boxed Warning on Severe Liver Injury with Propylthiouracil. www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ucm209023.htm (accessed April 20, 2013).
17. Emiliano AB, Governale L, Parks M, Cooper DS 2010 Shifts in propylthiouracil and methimazole prescribing practices: antithyroid drug use in the United States from 1991 to 2008. J Clin Endocrinol Metab 95:2227-2233.
18. MarketScan-Commercial Claims and Encounters database. Available from www.truvenhealth.com/your-healthcare-focus/pharmaceutical-And-medical-device/ data-databases-And-online-tools.aspx (accessed April 20, 2013).
19. International Classification of Diseases, Ninth Revision, Clinical Modification and Procedure Codes. Available from http://icd9cm.chrisendres.com/ index.php (accessed April 20, 2013).
20. American Medical Association Current Procedural Terminology procedure codes. Available from www.ama-Assn.org/ama/pub/physician-resources/solutions- managing-yourpractice/coding-billing-insurance/cpt.page (accessed April 20, 2013).
21. Hornbrook MC, Whitlock EP, Berg CJ, Callaghan WM, Bachman DJ, Gold R, Bruce FC, Dietz PM, Williams SB 2007 Development of an algorithm to identify pregnancy episodes in an integrated health care delivery system. Health Serv Res 42:908-927.
22. Bahn R, Burch H, Cooper D, Garber J, Greenlee C, Klein IL, Laurberg P, McDougall IR, Rivkees SA, Douglas R, Sosa JA, Stan MN 2009 The role of propylthiouracil in the management of Graves' disease in adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration. Thyroid 19:673-674.